Filed: 11/14/2022ACC: 0000950123-22-011914
📋 What this filing means
MWG MANAGEMENT LTD. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $259.6K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$259.6K
Total AUM (reported)
22.51M
Total Shares
Allocation by class
COM$259.6K100.0%
Portfolio Concentration
Top 3$259.6K100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 22.51M
Sole
Full voting authority
22.51M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other2
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
LYELL IMMUNOPHARMA INC
DFNDShares20.16M
TypeSH
Market value$147.8K
56.93%
Sole
20.16M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
DFNDShares2.35M
TypeSH
Market value$111.8K
43.07%
Sole
2.35M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LYELL IMMUNOPHARMA INCDFND | COM | 20.16M | SH | $147.8K 56.93% | 20.16M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCDFND | COM | 2.35M | SH | $111.8K 43.07% | 2.35M | 0.00 | 0.00 |